Let's Make things Better
JNS: Centre for DNA Fingerprinting and Diagnostics (CDFD), based at Hyderabad in India has initiated an inter-disciplinary approach to decode the genetic mutations that causes Paediatric Rare Genetic Disorders (PRaGeD). The …
CDFD initiates approach to decode Paediatric Rare Genetic Disorders Read More
Mumbai: Thermo Fisher Scientific today celebrated the inauguration of its new R&D and Engineering facility – India Engineering Center (IEC) – by Hon. Minister for Industries and Commerce, Government of …
Thermo Fisher Scientific Expands State-of-the-art R&D Facility in Hyderabad Read More
JNS I Hyderabad: Microsoft is all set to establish its largest data centre in India. In collaboration with the Telangana government, it would be proposed to come up in Hyderabad. …
Microsoft to set-up its largest data center in India with collaboration of Telangana Govt. Read More
Mumbai: India’s first credit & payment reporting Fintech platform, Recordent, plans to expand its Team and hire employees across the key verticals for offices in Mumbai and Hyderabad. Recordent has …
Recordent plans to expand its Team, hire employees across verticals Read More
New Delhi: Vedanta’s XStrat B-School case study competition came to a grand culmination, with the team from ISB Hyderabad winning the maiden season. IIM Ahmedabad lifted the 1st Runners Up award, …
ISB students wins Vedanta’s Case Study Competition Read More
Ashis Sinha I Bokaro: Bokaro Steel Plant (BSL), a unit of Steel Authority of India Limited (SAIL) has also signed a separate MoU with IIIT Hyderabad for use of latest …
BSL signs MoU with IIIT Hyderabad for Industry-4 steel production Read More
Ashis Sinha I JNS: The first dose of Sputnik V vaccine (imported) was administered in Hyderabad today. As part of a limited pilot, the soft launch of the vaccine has …
First dose of Sputnik V administrated in Hyderabad; costs Rs 995.40 each dose Read More
JNS: Covaxin, a coronavirus vaccine, developed in India by a Hyderabad-based company- Bharat Biotech, has reported overall interim clinical efficacy of 78 per cent, said Bharat Biotech and ICMR on …
Covaxin 100% effective against severe COVID-19: ICMR-Bharat Biotech Read More JNS: Covaxin, a coronavirus vaccine, developed by Bharat Biotech a Hyderabad-based company in India, has been found to be “safe with no serious side effects.” This is based on the …
Covaxin is safe, no significant side effects: Lancet Read More